Robert Montal
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 10
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Treatments and Studies 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Josep M. Llovet (9 shared papers)Daniela Sia (4 shared papers)Richard S. Finn (1 shared paper)Augusto Villanueva (4 shared papers)Myron Schwartz (2 shared papers)Edward Kim (1 shared paper)Michael Buckstein (1 shared paper)Florian Castet (1 shared paper)
- Journals
- Journal of Hepatology (3 papers)Cancers (2 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Clinical & Translational Oncology (1 paper)
- Partner nations
- SpainUnited StatesAustralia
In The Last Decade
Robert Montal
18 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Hepatology 921
- Cancer Research 682
- Oncology 614
- Pathology and Forensic Medicine 339
- Pulmonary and Respiratory Medicine 527
Countries citing papers authored by Robert Montal
This map shows the geographic impact of Robert Montal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Montal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Montal more than expected).
Fields of papers citing papers by Robert Montal
This network shows the impact of papers produced by Robert Montal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Montal. The network helps show where Robert Montal may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Montal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Molecular therapies and precision medicine for hepatocellular carcinoma Hit paper breakdown → | 2018 | 1392 |
| 2 | Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020) Hit paper breakdown → | 2021 | 165 |
| 3 | 2017 | 153 | |
| 4 | 2019 | 145 | |
| 5 | 2017 | 113 | |
| 6 | 2019 | 63 | |
| 7 | 2021 | 42 | |
| 8 | 2020 | 40 | |
| 9 | 2023 | 38 | |
| 10 | 2019 | 16 | |
| 11 | 2016 | 12 | |
| 12 | 2020 | 7 | |
| 13 | 2016 | 7 | |
| 14 | 2016 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2023 | 0 |
About Robert Montal
Robert Montal is a scholar working on Oncology, Hepatology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (4 papers), Head and Neck Cancer Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Head and Neck Surgical Oncology (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Hepatology (921 citations), Cancer Research (682 citations), Oncology (614 citations), Pathology and Forensic Medicine (339 citations) and Pulmonary and Respiratory Medicine (527 citations). Robert Montal has collaborated with scholars based in Spain, United States and Australia. Frequent co-authors include Josep M. Llovet, Daniela Sia, Richard S. Finn, Augusto Villanueva, Myron Schwartz, Edward Kim, Michael Buckstein, Florian Castet, Philipp K. Haber and Vennis Lourdusamy. Their work appears in journals such as Journal of Hepatology, Cancers, Molecular Cancer Therapeutics, Clinical Cancer Research and Clinical & Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.